1-8 of 8
J. Kaitlin Morrison
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Trial of CD30-Directed, CCR4 Co-Expressing Chimeric Antigen Receptor T-Cells in Patients with CD30 + Cutaneous T-Cell Lymphomas Refractory to Brentuximab Vedotin

Daniel K Reef, Catherine Joyce Arago Cheng, Caroline Babinec, Kelly Hoye, John West, J. Kaitlin Morrison, Faith Brianne Buchanan, Ashley Zanter, Angela Denise Spruill, Kimberly A. Kasow, Anastasia Ivanova, Edith Bowers, Jonathan Serody, Barbara Savoldo, Gianpietro Dotti, Natalie Grover, Anne W Beaven
Journal: Blood
Blood (2024) 144 (Supplement 1): 3468.
https://doi.org/10.1182/blood-2024-201799
Published: 2024
Journal Articles

CD30.CAR-T Cells Co-Expressing the CCR4 Chemokine Receptor in Relapsed/Refractory Hodgkin Lymphoma

Natalie Grover, Dominic Moore, Anastasia Ivanova, Anne W Beaven, Christopher Dittus, Catherine Joyce Arago Cheng, Kelly Hoye, Caroline Babinec, Faith Brianne Buchanan, Angela Denise Spruill, Ashley Zanter, John West, J. Kaitlin Morrison, Paul Armistead, Kimberly A. Kasow, Jonathan Serody, Gianpietro Dotti, Barbara Savoldo
Journal: Blood
Blood (2024) 144 (Supplement 1): 919.
https://doi.org/10.1182/blood-2024-200932
Published: 2024
Journal Articles

Abrogation of Immune Effector Cell Neurotoxicity Syndrome (ICANS) By Rimiducid (RIM) in Patients Treated with CD19-Specific Chimeric Antigen Receptor Modified T-Cells (CAR-T) Engineered with an Inducible Caspase 9 (iC9 CAR.19)-Clinical and Pharmacodynamic Correlates

Matthew C. Foster, Barbara Savoldo, Winnie Lau, Clio Rubinos, Natalie S. Grover, Paul M. Armistead, James M. Coghill, Jr., Katarzyna Joanna Jamieson, Robert Hagan, J. Kaitlin Morrison, Faith Brianne Buchanan, Catherine Joyce Arago Cheng, Anastasia Ivanova, Tammy Cavallo, John West, Megan Gonzalez, Jonathan S. Serody, Gianpietro Dotti
Journal: Blood
Blood (2022) 140 (Supplement 1): 7437–7438.
https://doi.org/10.1182/blood-2022-165558
Published: 2022
Journal Articles

Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma

Timothy J. Voorhees, Anne W. Beaven, Christopher Dittus, George E Hucks, J. Kaitlin Morrison, Catherine Joyce Arago Cheng, Tammy Cavallo, Steven I. Park, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo, Natalie S. Grover
Journal: Blood
Blood (2022) 140 (Supplement 1): 12723–12724.
https://doi.org/10.1182/blood-2022-156660
Published: 2022
Journal Articles

CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and Non-Hodgkin Lymphoma in Pediatric Patients

George E. Hucks, Jr., Barbara Savoldo, Gianpietro Dotti, Catherine Joyce Arago Cheng, Caroline Babinec, Kimberly A. Kasow, Michael Winstead, Arpita Patel, Cammie Presler, Natalie S Grover, J. Kaitlin Morrison, Anne W. Beaven, Marcie L. Riches, Thomas C. Shea, Jonathan S. Serody
Journal: Blood
Blood (2021) 138 (Supplement 1): 2829.
https://doi.org/10.1182/blood-2021-153968
Published: 2021
Journal Articles

CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma

Natalie S Grover, Anastasia Ivanova, Dominic T. Moore, Catherine Joyce Arago Cheng, Caroline Babinec, John West, Tammy Cavallo, J. Kaitlin Morrison, Faith Brianne Buchanan, Edith Bowers, Christopher Dittus, Anne W. Beaven, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo
Journal: Blood
Blood (2021) 138 (Supplement 1): 742.
https://doi.org/10.1182/blood-2021-148102
Published: 2021
Journal Articles

Retrospective Cohort Study Analyzing the Safety and Efficacy of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Timothy J Voorhees, MD, Natalie S Grover, MD, Anne Beaven, MD, Steven I Park, MD, J. Kaitlin Morrison, PhD, Catherine Joyce Arago Cheng, BS, Spencer Laing, BA, Gianpietro Dotti, MD, Barbara Savoldo, MD PhD, Jonathan S Serody, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3233.
https://doi.org/10.1182/blood-2019-122846
Published: 2019
Journal Articles

Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin

Natalie S Grover, MD, Steven I Park, MD, Anastasia Ivanova, PhD, Paul Eldridge, PhD, Kathryn McKay, MS, MT (ASCP), Catherine Joyce Arago Cheng, BS, Spencer Laing, BA, Deborah Covington, RN, BSN, John West, PhD, S. Elizabeth Sharf, RN, BSN, J. Kaitlin Morrison, PhD, Shaw Scott, Erin Crecelius, MA, Desirae Shelley, Maurice Alexander, PharmD, Faith Brianne Buchanan, PA, Emily Herrick Kassam, NP, Megan McElfresh, PA-C, Alicia R Pinto, NP, Angela Denise Spruill, ANP, Ashley Zanter, ANP, Kimberly Wehner, FNP, Christopher Dittus, DO, Thomas C. Shea, MD, Gianpietro Dotti, MD, Jonathan S Serody, MD, Anne Beaven, MD, Barbara Savoldo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 681.
https://doi.org/10.1182/blood-2018-99-113534
Published: 2018